Dopamine levels are lower, whereas the percentage of IL-17 and IFN-γ producing cells is higher in MS patients than in healthy subjects, suggesting a suppressive effect of dopamine in MS [73]. This evidence concerns the gene IL17A and myeloid sarcoma.